Literature DB >> 20070276

Female sexuality in multiple sclerosis: the multidimensional nature of the problem and the intervention.

Gila Bronner1, E Elran, J Golomb, A D Korczyn.   

Abstract

Female sexual functioning is a complex process involving physiological, psychosocial and interpersonal factors. Sexual dysfunction (SD) is frequent (40-74%) among women with multiple sclerosis (MS), reflecting neurological dysfunction, psychological factors, depression, side effects of medications and physical manifestations of the disease, such as fatigue and muscle weakness. A conceptual model for sexual problems in MS characterizes three levels. Primary SD includes impaired libido, lubrication, and orgasm. Secondary SD is composed of limiting sexual expressions due to physical manifestations. Tertiary SD results from psychological, emotional, social, and cultural aspects. Sexual problems cause distress and may affect the family bond. Practical suggestions on initiation of discussion of sexual issues for MS patients are included in this review. Assessment and treatment of sexual problems should combine medical and psychosexual approaches and begin early after MS diagnosis. Intervention can be done by recognizing sexual needs, educating and providing information, by letting patients express their difficulties and referring them to specialists and other information resources.

Entities:  

Mesh:

Year:  2010        PMID: 20070276     DOI: 10.1111/j.1600-0404.2009.01314.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  20 in total

1.  Management of sexual dysfunction in Parkinson's disease.

Authors:  Gila Bronner; David B Vodušek
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

Review 2.  Multiple sclerosis and sexual dysfunction.

Authors:  Zhen-Ni Guo; Si-Yuan He; Hong-Liang Zhang; Jiang Wu; Yi Yang
Journal:  Asian J Androl       Date:  2012-03-26       Impact factor: 3.285

3.  Multidisciplinary Management of Sexual Dysfunction, Perineal Pain, and Elimination Dysfunction in a Woman with Multiple Sclerosis.

Authors:  Michela Miletta; Fabrizio Bogliatto; Leonardo Bacchio
Journal:  Int J MS Care       Date:  2017 Jan-Feb

4.  Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled Trial.

Authors:  Laura De Giglio; Fabiana Marinelli; Valeria T Barletta; Veronica A Pagano; Floriana De Angelis; Fulvia Fanelli; Nikolaos Petsas; Patrizia Pantano; Valentina Tomassini; Carlo Pozzilli
Journal:  CNS Drugs       Date:  2017-02       Impact factor: 5.749

5.  Prevalence of Sexual Dysfunction in Women with Multiple Sclerosis: a Systematic Review and Meta-Analysis.

Authors:  Amirreza Azimi; Sara Hanaei; Mohammad Ali Sahraian; Mehdi Mohammadifar; Sreeram V Ramagopalan; Mahsa Ghajarzadeh
Journal:  Maedica (Buchar)       Date:  2019-12

6.  Sexual problems among women with multiple sclerosis.

Authors:  Effat Merghati-Khoei; Kowsar Qaderi; Leila Amini; Jeffrey E Korte
Journal:  J Neurol Sci       Date:  2013-06-10       Impact factor: 3.181

7.  The Assessment of Sexual Dysfunction in Male Patients with Multiple Sclerosis.

Authors:  Faruk Ömer Odabaş; Haluk Gümüş; Halil Ekrem Akkurt; Ali Ulvi Uca; Halim Yilmaz
Journal:  Noro Psikiyatr Ars       Date:  2018-07-05       Impact factor: 1.339

8.  Evaluation of Sexual Dysfunction in Females With Ankylosing Spondylitis.

Authors:  Halil Ekrem Akkurt; Halim Yilmaz; Sema Yilmaz; Lütfiye Parlak; Banu Ordahan; Ali Salli
Journal:  Arch Rheumatol       Date:  2015-11-27       Impact factor: 1.472

9.  Prevalence of Sexual Dysfunctions Among Women with Multiple Sclerosis.

Authors:  M Lew-Starowicz; R Rola
Journal:  Sex Disabil       Date:  2013-06

10.  Determinants of sexual dysfunction in women with multiple sclerosis.

Authors:  Khadijeh Mohammadi; Parvin Rahnama; Sakineh Moayed Mohseni; Mohammad Ali Sahraian; Ali Montazeri
Journal:  BMC Neurol       Date:  2013-07-12       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.